Puis-je l’obtenir ?
Oui, si un médecin estime que ce traitement vous convient. Avanafil 50/100/200mg est autorisé dans l’UE et peut être prescrit après une évaluation médicale.
Avanafil 50/100/200mgSur ordonnance uniquement
Consultation médicale en ligne pour Avanafil 50/100/200mg.
Un médecin agréé par l'UE examine votre cas et, si vous êtes éligible, délivre une ordonnance électronique valable dans toute pharmacie de l'UE en vertu de la directive 2011/24/UE.
- Onset as fast as 15–30 minutes
- The most recent PDE5 molecule
- Narrower side-effect profile in some studies
Débuter la consultationDébuter la consultation · 35 €
Remboursement intégral si un examen n'est pas approuvé · Le médicament, s'il est prescrit, est délivré et payé séparément en pharmacie.
EN TERMES SIMPLES
Ce qu’est Avanafil 50/100/200mg et comment obtenir un traitement
L’avanafil est un comprimé sur ordonnance contre les troubles de l’érection. Il est autorisé dans toute l’UE depuis 2013 et est le comprimé le plus récemment approuvé de ce groupe. Comme les autres, il maintient les vaisseaux sanguins du pénis détendus afin que le sang puisse y entrer pendant l’excitation sexuelle. Les informations européennes sur le produit indiquent que la dose habituelle de 100 mg se prend environ 15 à 30 minutes avant un rapport sexuel. Comme les autres médicaments de ce groupe, il ne doit jamais être pris avec des médicaments nitrés pour le cœur.
Avanafil 50/100/200mg est autorisé dans l’UE depuis le 21 juin 2013. Un médecin habilité peut donc vous le prescrire si ce traitement est adapté à votre situation médicale.
Que puis-je prendre à la place ?
Nos médecins examinent toutes les options de Santé sexuelle et recommandent celle qui correspond à vos antécédents et à vos objectifs.
Voir toutes les options de Santé sexuelleQue montrent les études ?
Tous les essais sur Avanafil 50/100/200mg sont répertoriés ci-dessous, avec leur numéro d’enregistrement, le nombre de participants et une indication précisant si les résultats ont été évalués par d’autres scientifiques ou proviennent d’une annonce de l’entreprise.
Voir les étudesDONNÉES VÉRIFIÉES
Avanafil 50/100/200mg : guide des données et de la réglementation.
DE QUOI S’AGIT-IL
Mode d’action
Avanafil blocks the PDE5 enzyme that normally ends an erection, letting the blood vessels in the penis stay relaxed and fill with blood when a man is sexually aroused.
- PDE5
STADE DE DÉVELOPPEMENT
Médicament autorisé dans l’UE
Registre des essais3 essais enregistrés
Chaque identifiant NCT renvoie vers ClinicalTrials.gov. Une annonce de résultats n’équivaut pas à une publication évaluée par les pairs.
| ESSAI / NCT | POPULATION | PARTICIPANTS | STATUT | RÉSULTAT / FIN |
|---|---|---|---|---|
| TA-301 — randomised, double-blind, placebo-controlled Phase 3 trialNCT00790751 | Men with mild to severe generalised erectile dysfunction | 646 | Résultats publiés | 2012-04-01 |
| TA-302 — randomised, double-blind, placebo-controlled Phase 3 trialNCT00809471 | Men with type 1 or type 2 diabetes and erectile dysfunction | 390 | Résultats publiés | 2012-08-01 |
| EU registration programme — four randomised, double-blind, placebo-controlled trials of up to 3 months | General erectile dysfunction, diabetic erectile dysfunction, and erectile dysfunction after bilateral nerve-sparing radical prostatectomy | 1,774 | Résultats publiés | — |
Résultats communiqués par les études
Les résultats sont séparés par source et niveau de preuve afin de ne pas confondre publications scientifiques et annonces du fabricant.
Évalué par les pairs
Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, Didonato K, Trask B, Day WW. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med 2012;9(4):1122-1133. doi:10.1111/j.1743-6109.2011.02629.x (PMID 22248153)| DOSE OU GROUPE | VARIATION MOYENNE DU POIDS | SEMAINES |
|---|---|---|
| 50 / 100 / 200 mg | Mean change in SEP2 and SEP3 success rates and in IIEF erectile function domain score significantly favoured every dose over placebo (p<=0.001) | 12 |
| 50 / 100 / 200 mg | Of 300 attempts made within 15 minutes of dosing, 64% to 71% were successful vs 27% on placebo | 12 |
| 50 / 100 / 200 mg | Of 80 attempts made more than 6 hours after dosing, 59% to 83% were successful vs 25% on placebo | 12 |
The 15-minute and 6-hour figures come from small subsets of attempts (300 and 80 respectively) inside a 12-week trial, so they are much less precise than the overall 12-week results.
Sources
Dernière révision 2026-07-27
- EMA EPAR — Spedra (avanafil), EMEA/H/C/002581, marketing authorisation issued 21/06/2013
- EMA — Spedra EPAR product information (SmPC sections 4.2, 4.8, 5.1; general-population success rates ~47% / 58% / 59% for 50 / 100 / 200 mg vs ~28% placebo)
- J Sex Med 2012 — Randomised, double-blind, placebo-controlled evaluation of avanafil (PMID 22248153)
- ClinicalTrials.gov — TA-301 avanafil Phase 3 trial (NCT00790751)
- ClinicalTrials.gov · NCT00790751
- ClinicalTrials.gov · NCT00809471
SIGNAUX DE SÉCURITÉ IDENTIFIÉS
Ce qui a été signalé avec Avanafil 50/100/200mg.
Headache
Listed as common in the EU product information — between 1 in 100 and 1 in 10 men — and named as one of the most frequently reported reactions across a safety database of 2,566 exposed subjects.
Flushing
Listed as common in the EU product information — between 1 in 100 and 1 in 10 men.
Nasal congestion
Listed as common in the EU product information — between 1 in 100 and 1 in 10 men. Sinus congestion is listed as uncommon.
Back pain
Listed as uncommon in the EU product information adverse-reaction table — between 1 in 1,000 and 1 in 100 men — although the safety summary names it among the most frequently reported reactions.
Dizziness and blurred vision
Both listed as uncommon in the EU product information — between 1 in 1,000 and 1 in 100 men.
Use with nitrates
Contraindicated with nitrate medicines and nitric-oxide donors, and in men with serious cardiovascular conditions such as recent heart attack, stroke or unstable angina.
35 € ponctuelDémarrer une consultation médicale
FormeComprimé oral
FréquenceÀ la demande
RésultatsActs in ~15–30 minutes
Ce que vous payez à Hi-Doctor35 € ponctuel
EN 60 SECONDES
Avanafil 50/100/200mg en bref
- A PDE5-inhibitor tablet taken by mouth
- Adult men with erectile dysfunction; sexual stimulation is still required
- One tablet 15 to 30 minutes before sex, at most one dose in 24 hours
- Nitrates and poppers are contraindicated: blood pressure can fall dangerously
- Hi-Doctor consultation fee; the medicine is paid separately at a pharmacy
INFOS SUR LA MARQUE
Spedra en bref
- TITULAIRE DE L'AUTORISATION DE MISE SUR LE MARCHÉ
- Menarini International Operations Luxembourg S.A.
- PRÉSENTATIONS
- 50 mg tablets · 100 mg tablets · 200 mg tablets
À propos du traitement
Qu'est-ce que Avanafil 50/100/200mg ?
Spedra contient la substance active avanafil.
Principe actif: Avanafil · Dosages: 50 / 100 / 200 mg on demand
Avanafil is the most recent PDE5 inhibitor, with fast onset (15–30 minutes) and a somewhat narrower side-effect profile in some studies. It's useful when timing flexibility matters.
It's prescribed at 50, 100 or 200 mg on demand, around 15–30 minutes before sexual activity. If there's no response, the doctor reassesses: dose adjustment, a switch to another PDE5, or evaluation of underlying causes — never a self-prescribed change.
MODE D'ACTION
Ce que Avanafil 50/100/200mg fait dans votre corps
Avanafil inhibits the PDE5 enzyme, improving penile blood flow in response to sexual stimulation. Its rapid absorption gives it one of the fastest onsets in the class.
Arousal releases nitric oxide
Avanafil does nothing on its own. When you are sexually aroused, nerves and blood-vessel lining in the penis release a gas called nitric oxide. That release is the trigger for everything that follows, which is why the EU product information states that sexual stimulation is required for the tablet to work.
Nitric oxide raises cGMP
Nitric oxide switches on an enzyme that makes cyclic guanosine monophosphate, usually shortened to cGMP. cGMP is the chemical messenger that tells the smooth muscle inside the erectile tissue to relax. As that muscle relaxes, blood flows into the penis faster than it drains away, and an erection builds.
Avanafil blocks the cGMP breaker
An enzyme called phosphodiesterase type 5, or PDE5, normally breaks cGMP down and ends the erection. Avanafil is described in the EU label as a highly selective, potent, reversible inhibitor of PDE5, so cGMP lasts longer and an erection is easier to reach and to keep.
Comment il aide
How it helps.
Fastest onset
Can act in as little as 15–30 minutes.
Modern molecule
The newest PDE5, with fewer vasomotor effects in some profiles.
Doctor-screened
The dose is tailored to your response and current medication.
À quoi s'attendre
How to take it.
On demand, shortly before sexual activity. The doctor tailors the dose to your response and current medication.
- Take it about 15–30 minutes before sexual activity
- The doctor starts from the dose that fits your case
- Never combine with nitrates
- If there's no response, the doctor reassesses — don't self-adjust
Doses your doctor can prescribe
- Available doses50 / 100 / 200 mg
- When~15–30 min before activity
Votre schéma est personnel
Ces étapes sont indicatives. Votre médecin ajuste le plan selon votre réponse et votre tolérance — et vous pouvez lui écrire à tout moment.
AU QUOTIDIEN
Utiliser Avanafil 50/100/200mg au quotidien
Take it 15 to 30 minutes ahead
Swallow one tablet by mouth roughly 15 to 30 minutes before sexual activity. That is the timing given in the EU product information for the usual 100 mg dose, and the same window applies to the 50 mg and 200 mg strengths.
Arousal is still required
The tablet does not cause an erection by itself. The label is explicit that sexual stimulation is needed for a response, because avanafil only extends a chemical signal that arousal starts in the first place.
One dose in 24 hours
The maximum recommended dosing frequency is once per day. Taking a second tablet because the first seemed not to work is outside the licence and raises the risk of low blood pressure, dizziness and fainting.
Food is allowed, fat slows it
You can take avanafil with or without food. A high-fat meal delays the peak blood level by about 1.25 hours on average and lowers it by about 39%, so a heavy meal beforehand can push back the onset.
Avoid grapefruit juice
Grapefruit juice inhibits the CYP3A4 enzyme that clears avanafil, which would raise the amount in your blood. The label advises avoiding grapefruit juice in the 24 hours before a dose.
Be careful with alcohol
Alcohol combined with avanafil made the drop in diastolic blood pressure significantly larger than either alone in a crossover study. Drinking raises the chance of dizziness, light-headedness or fainting after a dose.
Report back to your prescriber
Tell the prescriber whether the dose worked, how it was tolerated and what else you take. Any change of strength, or a decision to stop, is theirs to make with you rather than something to try alone.
La sécurité d'abord
La sécurité, dans son intégralité.
Avanafil 50/100/200mg est un médicament efficace — et, comme tout médicament, il comporte des risques. Votre médecin vérifie tout cela avant de prescrire. Voici le tableau honnête, pas seulement des paroles rassurantes.
Effets indésirables, par fréquence
Stop and get urgent medical help if
seek medical help immediately
these need urgent attention, whatever the frequency
- An erection lasts 4 hours or more, which is priapism and can permanently damage penile tissue
- Sudden loss or disturbance of vision in one or both eyes
- Sudden reduction or loss of hearing, sometimes with ringing in the ears and dizziness
- Chest pain or chest tightness during or shortly after sex
- Fainting, near-fainting or severe light-headedness after a dose
- Swelling of the face, lips, tongue or throat, a rash, or difficulty breathing
Common
common (≥1/100 to <1/10)
roughly between 1 in 100 and 1 in 10 people
- Headache
- Flushing, a warm reddening of the face and neck
- Blocked nose
Uncommon
uncommon (≥1/1,000 to <1/100)
roughly between 1 in 1,000 and 1 in 100 people
- Dizziness or drowsiness
- Sinus headache
- Blurred vision
- Palpitations, a noticeable heartbeat
- Hot flushes
- Blocked sinuses, or breathlessness on exertion
- Indigestion, nausea, vomiting or stomach discomfort
- Back pain or muscle tightness
- Tiredness
- Raised liver enzymes, a faster heart rate or an abnormal heart tracing on testing
Rare
rare (≥1/10,000 to <1/1,000)
roughly between 1 in 10,000 and 1 in 1,000 people
- Chest pain or angina, a fast heartbeat
- High or low blood pressure
- Runny nose, congested airways or nosebleed
- Dry mouth, gastritis, lower abdominal pain or diarrhoea
- Rash
- Flank pain, muscle aches or muscle spasms
- Passing urine more often
- Penile discomfort, an unprompted erection or genital itching
- Weakness, swollen ankles or a flu-like feeling
- Insomnia, premature ejaculation or restlessness
Dysfonction érectile chez l'homme adulte.
- Prenez un comprimé environ 15 à 30 minutes avant l'activité sexuelle.
- Maximum une dose par jour.
- La stimulation sexuelle reste nécessaire pour qu'il agisse.
- Un repas copieux ou riche en graisses retarde le début de l'effet.
QUI NE DOIT PAS LE PRENDRE ET QUI DOIT REDOUBLER DE PRUDENCE
- You use organic nitrates or nitric oxide donors in any form, including glyceryl trinitrate spray and amyl nitrite
- You take riociguat or another guanylate cyclase stimulator, because blood pressure can fall dangerously
- You take a potent CYP3A4 inhibitor such as ketoconazole, itraconazole, ritonavir, atazanavir, clarithromycin, indinavir, nefazodone, nelfinavir, saquinavir or telithromycin
- You have had a heart attack, a stroke or a life-threatening abnormal heart rhythm in the last 6 months
- Your resting blood pressure is below 90/50 mmHg or above 170/100 mmHg
- You have unstable angina, angina brought on by sex, or heart failure of New York Heart Association class 2 or above
- You have severe liver impairment (Child-Pugh class C) or severe kidney impairment (creatinine clearance below 30 mL/min)
- You have lost vision in one eye from non-arteritic anterior ischaemic optic neuropathy, or you have an inherited degenerative retinal disorder
- You are allergic to avanafil or to any of the tablet's other ingredients
- Do not combine it with other PDE5 inhibitors or other erectile-dysfunction treatments, because the combination is unstudied and raises the risk of prolonged erection; caution also applies if the penis is anatomically deformed, for example by angulation, cavernosal fibrosis or Peyronie's disease, or if you have a condition that predisposes to priapism such as sickle cell anaemia, multiple myeloma or leukaemia
Quand consulter en urgence
En cas de symptômes graves, soudains ou inattendus, appelez le numéro d'urgence local ou rendez-vous aux urgences les plus proches. Informez ensuite votre médecin via le chat de votre compte.
Médicaments et substances qui interagissent
| MÉDICAMENT OU SUBSTANCE | CE QUI PEUT ARRIVER | CE QUE FAIT LE MÉDECIN |
|---|---|---|
| Nitrates and nitric oxide donors (e.g. GTN spray, amyl nitrite) | Avanafil amplifies the blood-pressure-lowering effect of nitrates, which can become dangerous. | Absolute contraindication; the prescriber will not issue avanafil alongside nitrates. |
| Riociguat and other guanylate cyclase stimulators | Additive lowering of systemic blood pressure with no demonstrated clinical benefit. | Absolute contraindication; the prescriber chooses a different route for erectile dysfunction. |
| Potent CYP3A4 inhibitors (ketoconazole, ritonavir and similar) | Ketoconazole raised avanafil exposure about 14-fold and lengthened its half-life to roughly 9 hours. | Absolute contraindication; the prescriber checks every current medicine before issuing. |
| Moderate CYP3A4 inhibitors (erythromycin, diltiazem, verapamil, fluconazole) | Erythromycin roughly tripled avanafil exposure and lengthened its half-life to about 8 hours. | Caps the dose at 100 mg and no more than once every 48 hours. |
| Alpha-blockers (doxazosin, tamsulosin) | Additive widening of blood vessels can cause symptomatic low blood pressure in some men. | Starts avanafil at 50 mg, and only once you are stable on the alpha-blocker. |
| Other blood-pressure-lowering medicines (e.g. amlodipine, enalapril) | Small additive falls in blood pressure; amlodipine also raised avanafil exposure by about 60%. | Monitors blood pressure and warns you about dizziness on standing. |
| CYP3A4 inducers (rifampicin, carbamazepine, phenobarbital, efavirenz, bosentan) | May clear avanafil faster and reduce how well it works; this has not been studied. | Concomitant use is not recommended, so the prescriber reviews alternatives. |
| Grapefruit juice and alcohol | Grapefruit juice raises avanafil levels; alcohol deepens the fall in diastolic blood pressure. | Advises no grapefruit juice for 24 hours beforehand and caution with alcohol. |
Faire examiner votre cas par un médecinC'est exactement ce que le médecin vérifie avant toute prescription.
Lire le résumé de sécurité complet de Avanafil 50/100/200mgDONNÉES CLINIQUES
Ce que les essais cliniques ont montré
Avanafil's EU licence rests on four randomised, double-blind, placebo-controlled trials in 1,774 men, the programme reported by Goldstein and colleagues in 2012.
General population of men with erectile dysfunction
Placebo was about 28%. The 50 mg dose gave about 47% and 200 mg about 59%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)Men with erectile dysfunction · Single dose, measured at about 15 minutes
Time-to-onset study using the SEP3 measure. Placebo was 13.78% and the 200 mg dose gave 28.18%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)Men with type 1 or type 2 diabetes and erectile dysfunction
Placebo was about 21%, and 100 mg gave about 34%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)Men with erectile dysfunction after bilateral nerve-sparing radical prostatectomy
Placebo was about 9%.
Source: Spedra: EU Product Information (Summary of Product Characteristics and package leaflet)These figures are averages across groups of men in trials, not a forecast for any one person. A placebo tablet also worked some of the time, so the gap between avanafil and placebo is the meaningful part rather than the raw percentage. Results varied sharply by underlying cause, with much lower success rates after prostate surgery than in the general group, and an individual response can sit anywhere around these averages.
ALTERNATIVES
Avanafil next to the other PDE5 inhibitors
| MÉDICAMENT | VOIE D'ADMINISTRATION | FRÉQUENCE | PLAGE DE DOSES USUELLE | INDICATION AUTORISÉE DANS L'UE | PRINCIPALES DONNÉES |
|---|---|---|---|---|---|
| Sildenafil | Comprimé par voie orale | À la demande, jusqu'à une fois par jour | 25 to 100 mg | Treatment of men with erectile dysfunction; sexual stimulation is required. | EAU-cited trials: 56 to 84% reported improved erections |
| Tadalafil | Comprimé par voie orale | À la demande, ou 5 mg une fois par jour | 2.5 to 20 mg | Treatment of erectile dysfunction, and of the signs and symptoms of benign prostatic hyperplasia in adult men. | EAU-cited trials: 67 to 81% reported improved erections |
| Vardenafil | Comprimé par voie orale | À la demande, jusqu'à une fois par jour | 5 to 20 mg | Treatment of erectile dysfunction in adult men; sexual stimulation is required. | EAU-cited trials: 66 to 80% reported improved erections |
Vous ne savez pas lequel correspond à votre cas ? Le médecin examine vos antécédents et vous le dit.
Débuter la consultation · 35 €ACCÈS ET COÛT
Obtenir Avanafil 50/100/200mg et ce que cela coûte
Avanafil is prescription-only across the EU, so no pharmacy in any member state can supply it without a valid prescription. Who pays varies: the rows below record what each national medicines register or national formulary states, and say so plainly where the official source does not publish a reimbursement position.
Ce que vous payez à Hi-Doctor
35 € ponctuel
Répondez à quelques questions et un médecin agréé par l'UE examine votre cas en moins de 2 heures en moyenne. Remboursement intégral si ce n'est pas adapté à votre situation.
Ce que facture la pharmacie
Hi-Doctor ne vend, ne stocke ni ne délivre de médicaments et n'en fixe pas le prix. Le médicament se paie séparément en pharmacie ; le montant dépend du pays, de la taille du conditionnement, de l'existence d'un générique et de la prise en charge. La base de données officielle liée dans le tableau publie le prix autorisé en vigueur.
| PAYS | CONDITIONS DE DÉLIVRANCE | PRIS EN CHARGE PAR L'ASSURANCE MALADIE ? | SOURCE OFFICIELLE |
|---|---|---|---|
| Espagne | Médicament soumis à prescription médicale | Not stated by the national register | AEMPS CIMA |
Afficher les autres pays
| Allemagne | Médicament soumis à prescription médicale | Classed as a lifestyle preparation | PharmNet.Bund AMIce |
|---|---|---|---|
| France | Médicament soumis à prescription médicale | Not reimbursed | Base de données publique des médicaments |
| Italie | Médicament soumis à prescription médicale | Restricted — see national criteria | AIFA Medicinali |
| Pays-Bas | Médicament soumis à prescription médicale | Not in the GVS reimbursement system | CBG-MEB Geneesmiddeleninformatiebank |
| Portugal | Médicament soumis à prescription médicale | Not stated by the national register | INFARMED Infomed |
| Belgique | Médicament soumis à prescription médicale | Not stated by the national register | FAGG-AFMPS medicines database |
| Irlande | Médicament soumis à prescription médicale | Not stated by the national register | HPRA Find a Medicine |
| Autriche | Médicament soumis à prescription médicale | Not stated by the national register | BASG Medikamente Info Austria |
| Pologne | Médicament soumis à prescription médicale | Not stated by the national register | Rejestr Produktów Leczniczych |
TARIFS
Vous ne payez que si le traitement est approuvé.
35 € pour une consultation de santé sexuelle. Paiement unique, sans frais récurrents.
Santé sexuelle
PONCTUEL
35 € ponctuel
Une consultation, un médecin, une décision.
Rien n'est jamais stocké publiquement
Débuter la consultation
Remboursement intégral si un examen n'est pas approuvé
CE QUI EST INCLUS
- Consultation examinée par un médecin agréé dans l'UE
- Ordonnance électronique en cas d'approbation
- Remboursement intégral en cas de refus
Remboursement intégral si un examen n'est pas approuvé
Si un examen n’est pas approuvé, nous remboursons intégralement les 35 € de la consultation.
Remarque : Le médicament, si le médecin le prescrit, est payé séparément à la pharmacie au prix qu'elle fixe. Hi-Doctor ne vend pas de médicaments.
COMMENT LE MÉDECIN DÉCIDE
Un médecin inscrit à l'Ordre examine votre cas, pas un algorithme
Un médecin autorisé dans l'UE lit votre questionnaire et répond en moins de 2 heures en moyenne.
Si le médecin estime qu'une prescription n'est pas sûre, les frais de consultation sont intégralement remboursés.
Le suivi se fait dans la messagerie privée de votre compte, conformément au RGPD. Ni WhatsApp, ni SMS.
FOIRE AUX QUESTIONS
Questions sur Avanafil 50/100/200mg.
AUTRES TRAITEMENTS SANTÉ SEXUELLE
Découvrez les traitements connexes.
SOURCES
D'où proviennent ces informations
- 01
Spedra (avanafil): EPAR medicine overview — European Medicines Agency, 2026
- 02
Spedra: EU Product Information (Summary of Product Characteristics and package leaflet) — European Medicines Agency, 2026
- 03
Spedra 100 mg tablets: Summary of Product Characteristics — electronic medicines compendium (Datapharm), 2026
- 04
A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction — The Journal of Sexual Medicine 9(4):1122-33, 2012
- 05
EAU Guidelines on Sexual and Reproductive Health: Management of Erectile Dysfunction — European Association of Urology, 2026
- 06
Viagra (sildenafil): EPAR medicine overview — European Medicines Agency, 2026
- 07
Cialis (tadalafil): EPAR medicine overview — European Medicines Agency, 2026
- 08
Levitra (vardenafil): EPAR medicine overview — European Medicines Agency, 2025
- 09
CIMA: Spedra 50/100/200 mg comprimidos, authorised and marketed, prescription-only — AEMPS (Spanish Agency for Medicines and Medical Devices), 2026
- 10
Avanafil, human medicines with a currently valid German authorisation: 28 entries, Spedra 50, 100 and 200 mg tablets (Menarini International Operations Luxembourg S.A., EU/1/13/841) and parallel-distributed packs, all prescription-only — BfArM AMIce, public part, via PharmNet.Bund, Germany, 2026
- 11
§ 34 Abs. 1 SGB V: medicines used predominantly to improve sexual potency are excluded from statutory health insurance — Bundesministerium der Justiz, Germany, 2026
- 12
Base de données publique des médicaments: SPEDRA 50/100/200 mg, autorisation active, commercialisée, no reimbursement rate listed — ANSM / Ministère de la Santé (France), 2026
- 13
Banca Dati Farmaci: Spedra (avanafil), packs in classe C a totale carico dell'assistito and classe A with a therapeutic plan — AIFA (Italian Medicines Agency), 2026
- 14
Farmacotherapeutisch Kompas: avanafil (Spedra, Menarini Benelux), marked XGVS, not included in the GVS reimbursement system — Zorginstituut Nederland, 2026
- 15
INFOMED: Spedra (avanafil) 50/100/200 mg, Autorizado, at least one presentation marketed — INFARMED (Portuguese National Authority of Medicines), 2026
- 16
Geneesmiddelendatabank: Spedra 200 mg tabl., EU/1/13/841, availability recorded per pack, medisch voorschrift — FAGG / AFMPS (Belgian Federal Agency for Medicines and Health Products), 2026
- 17
Human Medicines authorised list: Spedra 50/100/200 mg tablets, registration status AU, supply through pharmacies only — HPRA (Health Products Regulatory Authority, Ireland), 2026
- 18
Medikamente Info Austria: Spedra 50/100/200 mg Tabletten, no discontinuation of marketing reported, repeat prescription, pharmacy supply — BASG (Austrian Federal Office for Safety in Health Care), 2026
- 19
Rejestr Produktów Leczniczych: Spedra (Avanafilum) 50/100/200 mg tabletki, centralised procedure, ATC G04BE10 — Ministry of Health / e-Zdrowie (Poland), 2026
Relu par l'équipe médicale de Hi-Doctor · Dernière relecture 2026-07-27 · Prochaine relecture prévue le 2027-07-27
Cette page fournit des informations sur un médicament. Elle ne constitue ni une recommandation de le prendre ni un substitut à une consultation médicale. Seul un médecin autorisé ayant examiné vos antécédents peut décider si un traitement vous convient.
Découvrez si c'est fait pour vous
Vérifiez si Avanafil 50/100/200mg est approprié pour vous.
Répondez à quelques questions et un médecin agréé par l'UE examine votre cas en moins de 2 heures en moyenne. Remboursement intégral si ce n'est pas adapté à votre situation.